Artificial Intelligence
The New Jersey health system's CIDO Sunil Dadlan explains how his teams have worked to implement effective and ethical AI, and offers perspective on challenges around regulations, workforce and interoperability.
And there are many other opportunities for automation to help reduce RN burnout, says Sophia Henry, clinical consultant at Beckman Coulter Diagnostics, who discusses some of the ethical considerations needed for responsible AI.
Rachini Moosavi, chief analytics officer at University of North Carolina Health, describes how and where AI is deployed at the health system – and says it plans to be ambitious in its deployments in 2024 while still being cautious.
In this latest in our series on top health IT voices talking artificial intelligence, Dr. Rebecca G. Mishuris shows how her health system is getting results with the advanced technology and discusses responsible use of AI.
The health system is piloting new tools to streamline workflows, such an ambient listening during patient exams, says Albert Marinez, its chief analytics officer. He describes some lessons learned during early-stage implementation.
With guidelines and rules for healthcare AI coming from the FDA, ONC, OCR, the White House and others, how will this regulatory framework change in 2024? Bryant Godfrey, partner at Foley Hoag, offers some thoughts.
For all its potential benefits for healthcare, it's still critical to understand how patient data is being collected and used for AI models, says Sara Shanti, a partner in Sheppard Mullin's Chicago-based Corporate Practice Group.
Andreessen Horowitz investment partner Jay Rughani discusses the paper he and his colleagues published recently about clinical use cases of AI, and outlined steps regulators should take for reimbursing providers using the technology.
The technology falsely tagged consumers, particularly women and people of color, as shoplifters, FTC says.
A new law passed in New York and legislation introduced in Ohio are just two of the latest examples of a legislative push to expand insurance coverage for biomarker testing.